Selective Blockade of the Capsaicin Receptor TRPV1 Attenuates Bone Cancer Pain
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
Cancer colonization of bone leads to the activation of osteoclasts, thereby producing local tissue acidosis and bone resorption. This process may contribute to the generation of both ongoing and movement-evoked pain, resulting from the activation of sensory neurons that detect noxious stimuli (nociceptors). The capsaicin receptor TRPV1 (transient receptor potential vanilloid subtype 1) is a cation channel expressed by nociceptors that detects multiple pain-producing stimuli, including noxious heat and extracellular protons, raising the possibility that it is an important mediator of bone cancer pain via its capacity to detect osteoclast- and tumor-mediated tissue acidosis. Here, we show that TRPV1 is present on sensory neuron fibers that innervate the mouse femur and that, in an in vivo model of bone cancer pain, acute or chronic administration of a TRPV1 antagonist or disruption of the TRPV1 gene results in a significant attenuation of both ongoing and movement-evoked nocifensive behaviors. Administration of the antagonist had similar efficacy in reducing early, moderate, and severe pain-related responses, suggesting that TRPV1 may be a novel target for pharmacological treatment of chronic pain states associated with bone cancer metastasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The capsaicin receptor: a heat-activated ion channel in the pain pathway
Caterina, M. J., Schumacher, M. A., Tominaga, M., Rosen, T. A., Levine, J. D., & Julius, D. (1997) · Nature · doi:10.1038/39807 · Cited by 9,107
Self-citationNeuronal plasticity: Increasing the gain in pain
Woolf, C. J., & Salter, M. W. (2000) · Science · doi:10.1126/science.288.5472.1765 · Cited by 3,781 · cited 1×
“In addition to agents that can directly activate TRPV1, other factors such as bradykinin, ATP, and NGF can modulate TRPV1 function indirectly via activation of second-messenger signaling pathways (Woolf and Salter, 2000; Julius and Basbaum, 2001), resulting in TRPV1 sensitization.”
BackgroundImpaired nociception and pain sensation in mice lacking the capsaicin receptor
Caterina, M. J., Leffler, A., Malmberg, A. B., Martin, W. J., Trafton, J., Petersen-Zeitz, K. R., Koltzenburg, M., Basbaum, A. I., & Julius, D. (2000) · Science · doi:10.1126/science.288.5464.306 · Cited by 3,544
Self-citationThe Cloned Capsaicin Receptor Integrates Multiple Pain-Producing Stimuli
Tominaga, M., Caterina, M. J., Malmberg, A. B., Rosen, T. A., Gilbert, H., Skinner, K., Raumann, B. E., Basbaum, A. I., & Julius, D. (1998) · Neuron · doi:10.1016/s0896-6273(00)80564-4 · Cited by 3,081
Self-citationMolecular mechanisms of nociception
Julius, D., & Basbaum, A. I. (2001) · Nature · doi:10.1038/35093019 · Cited by 2,685 · cited 2×
“…- induced pain behaviors is that other receptors ( such as bradykinin , P2X 3 , and prostaglandin receptors , or acid - sensing ion channel 3 and voltage - gated sodium channels ) may also be involved in the generation and maintenance of this pain state ( Julius and Basbaum , 2001 ; Mantyh et al .”
BackgroundSelf-citationInduction of c-fos-like protein in spinal cord neurons following sensory stimulation
Hunt, S. P., Pini, A., & Evan, G. (1987) · Nature · doi:10.1038/328632a0 · Cited by 1,972
Metastatic bone disease: clinical features, pathophysiology and treatment strategies
Coleman, R. E. (2001) · Cancer Treatment Reviews · doi:10.1053/ctrv.2000.0210 · Cited by 1,920
Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia
Davis, J. B., Gray, J., Gunthorpe, M. J., Hatcher, J. P., Davey, P. T., Overend, P., Harries, M. H., Latcham, J., Clapham, C., Atkinson, K., et al. (2000) · Nature · doi:10.1038/35012076 · Cited by 1,760
Skeletal complications of malignancy
Coleman, R. E. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19971015)80:8+<1588::aid-cncr9>3.0.co;2-g · Cited by 1,502
Ji, R.-R., Samad, T. A., Jin, S.-X., Schmoll, R., & Woolf, C. J. (2002) · Neuron · doi:10.1016/s0896-6273(02)00908-x · Cited by 1,238
Tsujino, H., Kondo, E., Fukuoka, T., Dai, Y., Tokunaga, A., Miki, K., Yonenobu, K., Ochi, T., & Noguchi, K. (2000) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.1999.0814 · Cited by 766
Breakthrough pain: characteristics and impact in patients with cancer pain
Portenoy, R. K., Payne, D., & Jacobsen, P. (1999) · Pain · doi:10.1016/s0304-3959(99)00006-8 · Cited by 689
Origins of skeletal pain: sensory and sympathetic innervation of the mouse femur
Mach, D. B., Rogers, S. D., Sabino, M. C., Luger, N. M., Schwei, M. J., Pomonis, J. D., Keyser, C. P., Clohisy, D. R., Adams, D. J., O’Leary, P., et al. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00165-3 · Cited by 677
Self-citationGriffiths, Jr. (1991) · British Journal of Cancer · doi:10.1038/bjc.1991.326 · Cited by 594
Coyle, N., Adelhardt, J., Foley, K. M., & Portenoy, R. K. (1990) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(05)80021-1 · Cited by 545
A receptor for protons in the nerve cell membrane
Krishtal, O. A., & Pidoplichko, V. I. (1980) · Neuroscience · doi:10.1016/0306-4522(80)90149-9 · Cited by 536
Neurochemical and Cellular Reorganization of the Spinal Cord in a Murine Model of Bone Cancer Pain
Schwei, M. J., Honore, P., Rogers, S. D., Salak-Johnson, J. L., Finke, M. P., Ramnaraine, M. L., Clohisy, D. R., & Mantyh, P. W. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-24-10886.1999 · Cited by 516
Self-citationMichael, G. J., & Priestley, J. V. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-05-01844.1999 · Cited by 506
Honore, P., Luger, N. M., Sabino, M. A. C., Schwei, M. J., Rogers, S. D., Mach, D. B., O'keefe, P. F., Ramnaraine, M. L., Clohisy, D. R., & Mantyh, P. W. (2000) · Nature Medicine · doi:10.1038/74999 · Cited by 498
Self-citationMolecular mechanisms of cancer pain
Mantyh, P. W., Clohisy, D. R., Koltzenburg, M., & Hunt, S. P. (2002) · Nature Reviews Cancer · doi:10.1038/nrc747 · Cited by 477
Self-citationProtons: small stimulants of capsaicin-sensitive sensory nerves
Bevan, S., & Geppetti, P. (1994) · Trends in Neurosciences · doi:10.1016/0166-2236(94)90149-x · Cited by 298
Chapter 8. Tissue acidosis in nociception and pain
Reeh, P. W., & Steen, K. H. (1996) · Progress in Brain Research · doi:10.1016/s0079-6123(08)61085-7 · Cited by 265
Sabino, M. A. C., Ghilardi, J. R., Jongen, J. L. M., Keyser, C. P., Luger, N. M., Mach, D. B., Peters, C. M., Rogers, S. D., Schwei, M. J., Felipe, C. D., et al. (2002) · PubMed · Cited by 225
Self-citationActions of bisphosphonate on bone metastasis in animal models of breast carcinoma
Yoneda, T., Michigami, T., Yi, B., Williams, P. J., Niewolna, M., & Hiraga, T. (2000) · Cancer · doi:10.1002/1097-0142(20000615)88:12+<2979::aid-cncr13>3.0.co;2-u · Cited by 214
Osteoprotegerin diminishes advanced bone cancer pain.
Luger, N. M., Honoré, P., Sabino, M., Schwei, M. J., Rogers, S. D., Mach, D. B., Clohisy, D. R., & Mantyh, P. W. (2001) · PubMed · Cited by 211
Self-citationTsuzuki, K., Kondo, E., Fukuoka, T., Yi, D., Tsujino, H., Sakagami, M., & Noguchi, K. (2001) · Pain · doi:10.1016/s0304-3959(00)00456-5 · Cited by 176
Priestley, J. V., Michael, G. J., Averill, S., Liu, M., & Willmott, N. (2002) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y02-034 · Cited by 175
Sevcik, M. A., Luger, N. M., Mach, D. B., Sabino, M. A. C., Peters, C. M., Ghilardi, J. R., Schwei, M. J., Röhrich, H., Felipe, C. D., Kuskowski, M. A., et al. (2004) · Pain · doi:10.1016/j.pain.2004.06.015 · Cited by 96
Self-citationde Wit, R., van Dam, F. S. A. M., Loonstra, S., Zandbelt, L. C., van Buuren, A., van der Heijden, K., Leenhouts, G., & Abu‐Saad, H. H. (2001) · Pain · doi:10.1016/s0304-3959(00)00455-3 · Cited by 92
Bisphosphonates in prostate carcinoma
Adami, S. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19971015)80:8+<1674::aid-cncr18>3.0.co;2-x · Cited by 89
Osteoclasts are required for bone tumors to grow and destroy bone
Clohisy, D. R., & Ramnaraine, M. L. R. (1998) · Journal of Orthopaedic Research® · doi:10.1002/jor.1100160606 · Cited by 84
Brain-metastatic melanoma: a neurotrophic perspective
Marchetti, D., Denkins, Y. M., Reiland, J., Greiter‐Wilke, A., Galjour, J., Murry, B. P., Blust, J., & Roy, M. (2003) · Pathology & Oncology Research · doi:10.1007/bf03033729 · Cited by 59
Drube, S., & Liebmann, C. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703764 · Cited by 42
Berenson (2001) · doi:10.1002/1097-0142(20010401)91:7<1191::aid-cncr1119>3.0.co;2-0
Cited by
Meijer, L., Nelson, D. J., Riazanski, V., Gabdoulkhakova, A. G., Hery-Arnaud, G., Le Berre, R., Loaëc, N., Oumata, N., Galons, H., Nowak, E., et al. (2016) · Journal of Innate Immunity · doi:10.1159/000444256 · Cited by 4,992
Transient Receptor Potential Cation Channels in Disease
Nilius, B., Owsianik, G., Voets, T., & Peters, J. A. (2007) · Physiological Reviews · doi:10.1152/physrev.00021.2006 · Cited by 1,399
Julius, D. (2013) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-101011-155833 · Cited by 1,140
Self-citationThe vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept
Szallasi, A., Cortright, D. N., Blum, C. A., & Eid, S. R. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2280 · Cited by 879
Trevisani, M., Siemens, J., Materazzi, S., Bautista, D. M., Nassini, R., Campi, B., Imamachi, N., Andrè, E., Patacchini, R., Cottrell, G. S., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705923104 · Cited by 770
Self-citation
Metadata
- Authors
- Ghilardi, J. R., Röhrich, H., Lindsay, T. H., Sevcik, M. A., Schwei, M. J., Kubota, K., Halvorson, K. G., Poblete, J., Chaplan, S. R., Dubin, A. E., Carruthers, N. I., Swanson, D., Kuskowski, M., Flores, C. M., Julius, D., & Mantyh, P. W.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2005-03-23
- Volume
- 25
- Issue
- 12
- Pages
- 3126-3131
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W2164144654
- Cited by
- 384
- References
- 34
- FWCI
- 9.31
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.